Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Mol Gastroenterol Hepatol ; 12(5): 1809-1830, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34237462

RESUMEN

BACKGROUND & AIMS: The gastrointestinal epithelium plays a crucial role in maintaining homeostasis with the gut microbiome. Mucins are essential for intestinal barrier function and serve as a scaffold for antimicrobial factors. Mucin 2 (MUC2) is the major intestinal gel-forming mucin produced predominantly by goblet cells. Goblet cells express anterior gradient 2 (AGR2), a protein disulfide isomerase that is crucial for proper processing of gel-forming mucins. Here, we investigated 2 siblings who presented with severe infantile-onset inflammatory bowel disease. METHODS: We performed whole-genome sequencing to identify candidate variants. We quantified goblet cell numbers using H&E histology and investigated the expression of gel-forming mucins, stress markers, and goblet cell markers using immunohistochemistry. AGR2-MUC2 binding was evaluated using co-immunoprecipitation. Endoplasmic reticulum (ER) stress regulatory function of mutant AGR2 was examined by expression studies in Human Embryonic Kidney 293T (HEK293T) using tunicamycin to induce ER stress. RESULTS: Both affected siblings were homozygous for a missense variant in AGR2. Patient biopsy specimens showed reduced goblet cells; depletion of MUC2, MUC5AC, and MUC6; up-regulation of AGR2; and increased ER stress. The mutant AGR2 showed reduced capacity to bind MUC2 and alleviate tunicamycin-induced ER stress. CONCLUSIONS: Phenotype-genotype segregation, functional experiments, and the striking similarity of the human phenotype to AGR2-/- mouse models suggest that the AGR2 missense variant is pathogenic. The Mendelian deficiency of AGR2, termed "Enteropathy caused by AGR2 deficiency, Goblet cell Loss, and ER Stress" (EAGLES), results in a mucus barrier defect, the inability to mitigate ER stress, and causes infantile-onset inflammatory bowel disease.


Asunto(s)
Susceptibilidad a Enfermedades , Enfermedades Inflamatorias del Intestino/etiología , Enfermedades Inflamatorias del Intestino/metabolismo , Mucosa Intestinal/metabolismo , Mucoproteínas/deficiencia , Moco/metabolismo , Proteínas Oncogénicas/deficiencia , Secuencia de Aminoácidos , Animales , Biomarcadores , Modelos Animales de Enfermedad , Estrés del Retículo Endoplásmico , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Predisposición Genética a la Enfermedad , Células Caliciformes/metabolismo , Células Caliciformes/patología , Humanos , Enfermedades Inflamatorias del Intestino/diagnóstico , Mucosa Intestinal/patología , Masculino , Ratones Noqueados , Mucinas/genética , Mucinas/metabolismo , Mucoproteínas/química , Mucoproteínas/metabolismo , Proteínas Oncogénicas/química , Proteínas Oncogénicas/metabolismo , Fenotipo , Análisis de Secuencia de ADN , Hermanos , Relación Estructura-Actividad , Secuenciación Completa del Genoma
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...